Greg Dadika, Assistant General Counsel, Litigation at C.R. Bard remarked “Each year, the ACI Drug and Medical Device Litigation conference continues to deliver the highest quality of speakers from around the nation discussing important and topical issues that we all face as litigators. It’s a must for any defense attorney in our industry.” Donald Bunnin, Litigation Counsel at Allergan, added that the conference is a “’can’t miss’ event that helps me stay informed on litigation trends and strategies.”
According to Stephanie Butler, Divisional Manager with ACI, the early response to the program is unprecedented, but not entirely unexpected. “I’ve worked on this event for 7 years and never seen a response like this, but the program this year features more in-house participation than ever before, so it’s not surprising that law firms especially are jumping at the opportunity to take advantage of the extensive networking and business development opportunities at the conference in what has become a highly competitive market.”
In addition to the stellar faculty including more than 30 in-house counsel, attendees will have a unique opportunity to hear candid views from 5 members of the state and federal bench.
Full information on the forum can be found at:
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.
Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.
Headquartered in New York and led by Benjamin J. Greenzweig, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.
Visit us at http://americanconference.com for more information.